Latest Distributions News

Osmond Resources has released final assays from its Phase 1 drilling at the Orión EU Critical Minerals Project in Spain, revealing significant enrichment of titanium, zirconium, and rare earth elements over a 10km strike. The discovery of a new basal mineralised seam adds to the project's scale, with Phase 2 drilling imminent and a Scoping Study targeted for late 2026.

Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.

Red Metal Limited is progressing key rare earth and base metal projects across Australia, securing government grants and proposing a major Maronan Metals share distribution to shareholders.

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

Golden Horse Minerals delivered robust drilling results at Southern Cross in Q1 2026, including visible gold at depth and strong shallow intercepts, supported by a healthy cash reserve of $39.3 million.

First Graphene has secured advanced graphene coatings technology through the AU$250,000 acquisition of Ionic Industries and Imagine Intelligent Materials, gaining immediate entry into lucrative geotextile and environmental infrastructure sectors.

Algorae Pharmaceuticals has struck an exclusive commercial and licensing agreement with global pharma Zydus Lifesciences to bring 10 injectable, oral, and specialty medicines to Australia and New Zealand, pending regulatory approvals.

Singular Health boosted its US presence by deploying 500 additional 3DICOM MD® licenses to Provider Network Solutions, securing FDA 510(k) clearance for its cloud platform, and launching education pilots with Miami-Dade schools and Florida International University.

Butn Limited has signed a memorandum of understanding with a major global bank to launch buyer-led supply chain finance programs in Australia, leveraging Butn’s proprietary platform and the bank’s funding capacity.

Vitrafy Life Sciences completed Phase II of its U.S. Military platelet cryopreservation study with strong results for a simplified no-wash process, accelerating commercial interest and progressing FDA device registration despite manufacturing delays.

Yandal Resources has confirmed a 100m southeast extension of high-grade gold mineralisation at its Arrakis discovery, with significant new RC drill results supporting underground exploration potential.

ECS Botanics reports a third straight quarter of positive operating cash flow, driven by strong B2C growth and strategic international shipments to Germany and New Zealand.